Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,506 | -62,872 | -140,848 | -77,474 | -47,550 |
| Depreciation Amortization | 5,496 | 2,293 | 8,533 | 5,905 | 3,959 |
| Accounts receivable | 8,938 | 10,105 | -9,409 | 174 | -109 |
| Accounts payable and accrued liabilities | 1,146 | -5,389 | 2,628 | 3,208 | -1,530 |
| Other Working Capital | -43,876 | -25,233 | 228,662 | 226,246 | 245,813 |
| Other Operating Activity | 48,223 | 19,788 | 81,746 | 37,282 | 24,368 |
| Operating Cash Flow | $1,421 | $-61,308 | $171,312 | $195,341 | $224,951 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -92,610 | -65,875 | -240,703 | -8,065 | -40,000 |
| PPE Investments | -10,530 | -5,778 | -23,567 | -15,368 | -11,437 |
| Sale Of Investment | N/A | 38,268 | 122,592 | N/A | 47,545 |
| Investing Cash Flow | $-103,140 | $-33,385 | $-141,678 | $-23,433 | $-3,892 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,731 | 1,885 | 11,305 | 10,490 | 7,735 |
| Financing Cash Flow | $3,731 | $1,885 | $11,305 | $10,490 | $7,735 |
| Exchange Rate Effect | -38 | -39 | -88 | N/A | N/A |
| Beginning Cash Position | 184,434 | 184,434 | 143,583 | 143,583 | 143,583 |
| End Cash Position | 86,408 | 91,587 | 184,434 | 325,981 | 372,377 |
| Net Cash Flow | $-98,026 | $-92,847 | $40,851 | $182,398 | $228,794 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,421 | -61,308 | 171,312 | 195,341 | 224,951 |
| Capital Expenditure | -10,530 | -5,778 | -23,567 | -15,368 | -11,437 |
| Free Cash Flow | -9,109 | -67,086 | 147,745 | 179,973 | 213,514 |